The U.S. Army yesterday issued a revised and updated safety policy for microbiology and biomedical laboratories. The new policy “prescribes the technical safety requirements for the use, handling, transportation, transfer, storage, and disposal of infectious agents and toxins (IAT) rated at biosafety level 2 (BSL–2) and above.” It applies to “all U.S. Army activities and facilities in which IAT are used.”
“Microbiological and biomedical activities are conducted by the U.S. Army in developing measures to identify, detect, diagnose, treat, and protect against IAT,” the 45 page document explains. See “Safety Standards for Microbiological and Biomedical Laboratories” (pdf), U.S. Army Pamphlet 385-69, May 6, 2009.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.